Matthew Sarabura
Matthew Sarabura is the national payer manager at Celltrion, a global drugmaker based in South Korea with offices in Canada, and he was recently in the news regarding the delays in the approval of three biosimilar drugs submitted to Health Canada.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 6.00 | 0.08% | +0% | 38,005,238 | 29,145 | $1,700,000 | 1,304$ |
| Totals | 1 | 38,005,238 | 29,145 | $1,700,000 | 1,304$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Matthew Sarabura, national payer manager at Celltrion, said the company expected to have all three drugs ready for patients this June.
6